Search results
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 5 days agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
Blood test that detects colon cancer close to receiving FDA approval
News 12· 2 hours agoA blood test that detects colon cancer is one step closer to being approved by the Food and Drug Administration. The Guardant Shield blood test has been ...
US FDA approves Biocon unit’s biosimilar to blockbuster eye drug Eylea
WHTC 1450 Holland· 5 days ago(Reuters) - The U.S. Food and Drug Administration on Monday approved Biocon unit's biosimilar to...
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 3 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
FDA denies Ipsen's citizen petition for blockbuster drug Somatuline
Endpoints News· 1 day agoUS drug regulators have turned down Ipsen’s effort to slow down generic competition for its blockbuster drug Somatuline Depot, which is used to slow the ...
One year after FDA approves over-the-counter birth control pill, advocates push for more access
Idaho Capital Sun via Yahoo News· 5 days ago“My parents are immigrants from India, and it’s been over the counter there since my mom can...
FDA approves CorTec’s implant system for stroke rehabilitation study
Medical Device Network via Yahoo Finance· 1 day agoPatient enrolment and the inaugural implantation of the neural interfacing system are scheduled for...
FDA advisers weigh benefits of weekly insulin for people with diabetes
WEVV Evansville· 24 hours agoNow, the maker of a once-weekly insulin injection is seeking approval from the US Food and Drug Administration, but a committee of agency advisers is divided on whether the ...
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Investor's Business Daily· 1 day agoGuardant Health stock jumped Friday after a Food and Drug Administration panel recommended the...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 1 day agoNeedham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...